Skip to Content
Stock Strategist

We Put This Pharma IPO to the Test

Cumberland Pharmaceutical is already profitable, but is it worth the offer price?

Mentioned: ,

This report is made available compliments of Morningstar IPO Research Services. For more information on Morningstar IPO Research, please contact Marc DeMoss at marc.demoss@morningstar.com or +1 312 384-4052.

After a slow July, it appears that August could be hot for IPOs. While it would seem reasonable to assume August is typically a slow month on Wall Street, it's actually been pretty busy historically. Once again, health-care related firms appear to be taking the lead, something that we have been predicting for months.

Bill Buhr does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.